
|Articles|August 1, 2018
- Pharmaceutical Executive-08-01-2018
- Volume 38
- Issue 8
Pharmaceutical Executive, August 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Emerging Biotech: Innovation, Location, and Inspirationover 7 years ago
Cross-Border Funding in the Life Sciencesover 7 years ago
Face It. You’re Not a Biotech Anymoreover 7 years ago
The Pulse of Biopharma M&Aover 7 years ago
The Big Apple’s Fresh Start in Biotechover 7 years ago
‘Emerging’ Product Launch Strategiesover 7 years ago
Biotech Investment: Reigning in Spainover 7 years ago
Traditional Scientific Search is Brokenover 7 years ago
Tough Fight Looms in Preserving R&D Incentivesover 7 years ago
From Science to SuccessNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Regeneron Focusing on Broad Pipeline Development
2
What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference?
3
President Trump Asks Congress to Enact 'The Great Healthcare Plan:' Report
4
Novartis Calls for Global Governments to Address Global Trade Policy
5




